Sun Pharmaceutical Industries Limited (Sun Pharma) informed the bourses on Tuesday that the company has launched FluGuard (Favipiravir 200 mg). The company has launched this medicine at a very affordable price i.e. Rs 35 per tablet. It will be used to treat patients having a mild to moderate COVID-19 disease. The stocks of FluGuard would be available in the market, starting this week. Favipiravir is the only oral anti-viral treatment approved in India for the potential treatment of...